Supernus Pharma (SUPN) Misses Q4 EPS by 25c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Supernus Pharma (SUPN) Misses Q4 EPS by 25c

Supernus Announces Fourth Quarter and Full Year 2022 Financial Results

February 28, 2023 4:06 PM EST

Full Year 2022 total revenues of $667.2 million, a 15% increase compared to full year 2021
Fourth quarter 2022 Qelbree® net product sales of $23.6 million increased 29% compared to third quarter of 2022; Full year 2022 Qelbree net product sales of $61.3 million, compared to $9.9 million for full year 2021Executed a second significant pharmacy benefit manager contract for QelbreeFourth quarter 2022 GOCOVRI® net product sales of $29.2 million increased 13% compared to fourth quarter of 2021; Full year 2022 GOCOVRI net product sales of $104.4 million increased... More